Beyond just storing structures, 3decision® enriches each entry with detailed metadata and sequence information. This includes information on pockets, protein-ligand interactions, antibody annotations, electron density maps and other crucial project data. By linking these diverse types of information, 3decision® transforms into a robust structural knowledge database, facilitating deeper insights and more efficient data utilization from a single platform.

3decision® has advanced analytical tools to identify druggable sites, assess off-target risks, and inspire new drug designs. The software analyses each structure upon registration, detecting all putative and known binding sites on the protein surface, indexing pharmacophoric features, and enabling sophisticated analyses such as binding site comparisons. The platform’s organization of data and analytics features converts massive amounts of structural information into useful knowledge, driving decision-making in drug discovery projects.

3decision® is designed to foster collaboration across different teams and locations through its cloud-based platform. The web-based UI enables to easily share insights and structural data, so project teams can seamlessly communicate and coordinate efforts in structure-guided drug design. Experts can expose complex data in an easily accessible way to non-experts, ensuring that everyone can visualize and analyze 3D structures effectively. The data in the platform are organized in projects with different levels of accessibility, allowing easier navigation and controlled data access.